rupiya.io
⠋Loading...
0%
❯ Fetching latest market data...
Dr. Agarwals Health Care Ltd is a Medical Instruments & Supplies company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Dr. Agarwals Health Care Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Medical Instruments & Supplies. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Healthcare.
Create a free account to view momentum, moving averages, and delivery signals.
Upgrade to view volatility, drawdown, factor, and risk metrics.
| Period | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|
| Sales | ₹531 Cr | ₹471 Cr | ₹696 Cr | |||
| Expenses | ₹407 Cr | ₹387 Cr | ₹510 Cr | |||
| Operating Profit | ₹124 Cr | ₹85 Cr | ₹186 Cr | |||
| OPM % | 23.0% | 18.0% | 27.0% | |||
| Other Income | ₹13 Cr | ₹6 Cr | ₹17 Cr | |||
| Depreciation | ₹93 Cr | ₹95 Cr | ₹98 Cr | |||
| Interest | ₹54 Cr | ₹44 Cr | ₹49 Cr | |||
| Profit Before Tax | ₹-11 Cr | ₹-48 Cr | ₹57 Cr | |||
| Tax | ₹-11 Cr | ₹-48 Cr | ₹57 Cr | |||
| Net Profit | ₹-21 Cr | ₹-59 Cr | ₹43 Cr | |||
| EPS (₹) | 0.0 | 0.0 | 0.0 | |||
| Dividend Payout % | 0% | 0% | 0% |
Register free to see 3 more years.
| Quarter | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Sales | ₹333 Cr | ₹349 Cr | ₹403 Cr | ₹417 Cr | ||||
| Expenses | ₹244 Cr | ₹241 Cr | ₹300 Cr | ₹310 Cr | ||||
| Operating Profit | ₹89 Cr | ₹108 Cr | ₹104 Cr | ₹107 Cr | ||||
| OPM % | 27.0% | 31.0% | 26.0% | 26.0% | ||||
| Depreciation | ₹43 Cr | ₹47 Cr | ₹56 Cr | ₹57 Cr | ||||
| Interest | ₹22 Cr | ₹27 Cr | ₹27 Cr | ₹28 Cr | ||||
| Net Profit | ₹23 Cr | ₹41 Cr | ₹18 Cr | ₹21 Cr | ||||
| EPS (₹) | 0.0 | 0.0 | 0.0 | 0.0 |
Register free to see 4 more quarters.
| Period | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity Capital | ₹7 Cr | ₹7 Cr | ₹7 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reserves | ₹242 Cr | ₹177 Cr | ₹206 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Borrowings | ₹162 Cr | ₹185 Cr | ₹633 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other Liabilities | ₹339 Cr | ₹417 Cr | ₹179 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total Liabilities | ₹751 Cr | ₹787 Cr | ₹1,025 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Assets | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fixed Assets | ₹551 Cr | ₹575 Cr | ₹701 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Investments | ₹1 Cr | ₹0 Cr | ₹0 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Receivables | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Inventory | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cash & Equivalents | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other Assets | ₹192 Cr | ₹201 Cr | ₹295 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total Assets | ₹751 Cr | ₹787 Cr | ₹1,025 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Register free to see 3 more years.
| Period | Operating | Investing | Financing | Net Cash Flow |
|---|---|---|---|---|
| Mar 2021 | ₹103 Cr | ₹-85 Cr | ₹-73 Cr | — |
| Mar 2022 | ₹99 Cr | ₹-46 Cr | ₹-37 Cr | — |
| Mar 2023 | ₹164 Cr | ₹-155 Cr | ₹35 Cr | — |
| Mar 2024 | ||||
| Mar 2025 |
Register free to see 3 more years.
No dividend history available.
No corporate actions recorded.
| Company | M.Cap | P/E | ROE | 1Y Return |
|---|---|---|---|---|
| Fabtech Technologies Ltd | ₹669 Cr | 15.0 | +12.94% | -37.68% |
| Fischer Medical Ventures Ltd | ₹2,284 Cr | 59.2 | 0.00% | -51.94% |
| Inventurus Knowledge Solutions Ltd | ₹26,681 Cr | 37.7 | 0.00% | -3.62% |
| Indegene Ltd | ₹12,256 Cr | 28.0 | +13.94% | +0.28% |
| Krsnaa Diagnostics Ltd | ₹1,837 Cr | 23.2 | 0.00% | -30.19% |
Create a free account to see institutional ownership snapshots.
Create a free account to view recent director and promoter trades.
Create a free account to view recent institutional deal activity.
Create a free account to view analyst estimate summaries.
Create a free account to view ESG risk and governance summaries.
Upgrade to view issuer ratings, instruments, outlooks, and rating history.
rupiya.io is for research and education only. Metrics shown are not investment advice. Validate with SEBI-regulated disclosures before acting.